Stay updated on Napabucasin Combo With FOLFIRI in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Napabucasin Combo With FOLFIRI in Colorectal Cancer Clinical Trial page.

Latest updates to the Napabucasin Combo With FOLFIRI in Colorectal Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has been updated to include new information about the trial involving Irinotecan and Bevacizumab for colorectal cancer, while significant details about the previous trial design and inclusion criteria have been removed.SummaryDifference28%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.6%
- Check88 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.6%
Stay in the know with updates to Napabucasin Combo With FOLFIRI in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Napabucasin Combo With FOLFIRI in Colorectal Cancer Clinical Trial page.